The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome

<h3>Background</h3><p dir="ltr">Polycystic ovary syndrome (PCOS) is associated with an adverse cardiovascular risk profile including a prothrombotic state. Exenatide has been shown to be effective at improving insulin sensitivity and weight loss in PCOS; therefore this st...

Full description

Saved in:
Bibliographic Details
Main Author: Alison J. Dawson (18175003) (author)
Other Authors: Thozhukat Sathyapalan (704787) (author), Rebecca Vince (17023392) (author), Anne-Marie Coady (18140278) (author), Ramzi A. Ajjan (3617486) (author), Eric S. Kilpatrick (6684365) (author), Stephen L. Atkin (6684368) (author)
Published: 2019
Subjects:
Biomedical and clinical sciences
Clinical sciences
Reproductive medicine
polycystic ovary syndrome
exenatide
cardiovascular risk
endothelial function
inflammation
blood clot function
GLP-1 receptor agonists
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items